the benefits of glp 1 drugs beyond obesity GLP-1-based therapies for diabetes, and GLP-1 and health: Beyond weight
Description
Ann Intern Med 141(11):84650
This disease spectrum ranges from isolated lipid deposition within hepatocytes through metabolic dysfunction-associated steatohepatitis (MASH), potentially advancing toward cirrhotic transformation, hepatic functional deterioration, and malignant hepatocellular transformation
Circulation 142(17):e265e286 American Diabetes Association Professional Practice Committee (2024) 10
Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis
When starting, 0.25 mg is taken for the first four doses before increasing to a higher dose
Louis, Dr
